News Releases

Ohio Attorney General Mike DeWine today released concealed carry license statistics for the third quarter of 2013 reporting 32,618 concealed carry licenses were issued.

Ohio Attorney General Mike DeWine today announced lawsuits against two Northeast Ohio home improvement contractors. The lawsuits accuse Mark Walker of Avon, and his business, All American Restoration, and Wayne Given of Silver Lake, doing business as Basement Waterproofing Solutions, of failure to deliver and performing shoddy work.

Ohio Attorney General Mike DeWine today announced a lawsuit against Form Giant LLC, the Cincinnati-based business that operates Change-My-Address.com. Consumers across the country mistakenly believed the website was associated with the United States Postal Service (USPS).

Ohio Attorney General Mike DeWine announced today that the Bureau of Criminal Investigation (BCI) has completed its investigation into the July officer-involved shooting death of a Village resident

As Ohioans prepare to honor service members on Veterans Day, Attorney General Mike DeWine is warning donors to beware of veterans’ charity scams and those who make false promises to help veterans.

Ohio Attorney General Mike DeWine and Springfield Police Chief Stephen Moody today announced the arrest of a man on a charge of Importuning after he allegedly solicited an undercover officer online.

Ohio Attorney General Mike DeWine announced today that more than 500 Ohio peace officers will receive free traffic safety training offered by the Ohio Peace Officer Training Academy (OPOTA), which is a division of the Ohio Attorney General's Office. 

Ohio Attorney General Mike DeWine today filed a lawsuit charging Cleveland-area business Tours of the Month Inc. and owner Edward Haak with failing to deliver vacation tour packages to consumers and failing to provide refunds.

Ohio Attorney General Mike DeWine announced today that Ohio has joined with several other states and the federal government in a global settlement with New Jersey pharmaceutical manufacturer Johnson & Johnson (J & J) and its subsidiary, Janssen Pharmaceuticals, Inc., to resolve civil and criminal allegations of unlawful marketing practices to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega.